Literature DB >> 7151852

Pethidine binding to blood cells and plasma proteins in old and young subjects.

L Holmberg, I Odar-Cederlöf, J L Nilsson, M Ehrnebo, L O Boréus.   

Abstract

The distribution of 3H-pethidine in whole blood was compared in old (63-86 years; n = 11) and young (19-25 years, n = 12) subjects using equilibrium dialysis. The plasma protein binding was 52.7 +/- 3.3% (mean +/- SD) in the old subjects and 51.8 +/- 3.1% in the young: the difference was not statistically significant. Studies on isolated plasma protein fractions showed that the main pethidine-binding protein was alpha 1-acid glycoprotein. Accordingly, the degree of pethidine binding is likely to be affected by inflammatory disease rather than by age. The distribution of pethidine to blood cells showed no age-related difference; the ratio between whole blood and plasma concentrations was 0.99 in old and 0.98 in young subjects. In whole blood from old and young subjects, 43% and 41% of pethidine was present in erythrocytes, 27% and 26% in plasma water whereas 30% and 29% was bound to plasma proteins. The mean ratio between pethidine in cells and plasma water (2.01) indicates binding of the drug in or on the blood cells. These in vitro results do not support the previous theory that a decrease in intracellular pethidine distribution in old age was the reason for the reported higher plasma levels. A slower elimination rate remains the most likely explanation for the increased plasma concentration of pethidine in old patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7151852     DOI: 10.1007/bf00605998

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  35 in total

1.  Factors affecting drug binding in plasma of elderly patients.

Authors:  S Wallace; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

2.  Uptake of acetazolamide by human erythrocytes in vitro.

Authors:  S M Wallace; S Reigelman
Journal:  J Pharm Sci       Date:  1977-05       Impact factor: 3.534

3.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

4.  Drug-induced illness leading to hospitalization.

Authors:  G J Caranasos; R B Stewart; L E Cluff
Journal:  JAMA       Date:  1974-05-06       Impact factor: 56.272

5.  Pentazocine binding to blood cells and plasma proteins.

Authors:  M Ehrnebo; S Agurell; L O Boréus; E Gordon; U Lönroth
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

6.  Complex formation between macromolecules and drugs. IV. Binding of sulfa drugs to human serum albumin at varying pH values.

Authors:  R Elofsson; S O Nilsson; A Agren
Journal:  Acta Pharm Suec       Date:  1970-11

7.  Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors:  M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

8.  Meperidine kinetics in man. Intravenous injection in surgical patients and volunteers.

Authors:  L E Mather; G T Tucker; A E Pflug; M J Lindop; C Wilkerson
Journal:  Clin Pharmacol Ther       Date:  1975-01       Impact factor: 6.875

9.  Binding-site interaction of chlorthalidone and acetazolamide, two drugs transported by red blood cells.

Authors:  B Beermann; K Hellström; B Lindström; A Rosén
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

10.  Predisposing factors in adverse reactions to drugs.

Authors:  N Hurwitz
Journal:  Br Med J       Date:  1969-03-01
View more
  6 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

3.  Effect of age and sex on the plasma binding of acidic and basic drugs.

Authors:  R K Verbeeck; J A Cardinal; S M Wallace
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Pethidine binding in plasma: effects of methodological variables.

Authors:  C La Rosa; L E Mather; D J Morgan
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

Review 5.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

6.  CSF and plasma pharmacokinetics of intramuscular morphine.

Authors:  G Nordberg; L Borg; T Hedner; T Mellstrand
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.